iJak 381
Alternative Names: iJak-381; Jak1 inhibitor Genentech/Roche; Janus Kinase 1 inhibitor; Janus Kinase 1 inhibitor - Genentech/RocheLatest Information Update: 28 Jun 2023
At a glance
- Originator Genentech; Roche
- Class Amides; Anti-inflammatories; Antiasthmatics; Chlorobenzenes; Fluorinated hydrocarbons; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Small molecules
- Mechanism of Action Janus kinase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 28 Jun 2023 No recent reports of development identified for preclinical development in Asthma in Switzerland (Inhalation, Powder)
- 28 Jun 2023 No recent reports of development identified for preclinical development in Asthma in USA (Inhalation, Powder)
- 10 Oct 2019 Chemical structure information added